ClinicalTrials.gg
Sign In

Intracranial Arteriosclerosis clinical trials

The registry lists 102 studies for Intracranial Arteriosclerosis across more than 10 countries. 48 are recruiting or about to start. 53 of them are mainly about Intracranial Arteriosclerosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Dementia, Vascular: 315 studies, 108 open.

Get an email when these change. Save the Intracranial Arteriosclerosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
31
Recruiting
28
Not yet recruiting
20
Status unknown
12
Active, not recruiting
4
Terminated
4

Phase

Phase 4
16
Phase 3
11
Phase 2
7
Phase 1
2
Early Phase 1
1

Where

China
44
United States
17
Hong Kong
5
Vietnam
4
Korea, Republic of
3
Egypt
2

Who runs them

Xuanwu Hospital, Beijing (6) · Chinese University of Hong Kong (5) · National Heart, Lung, and Blood Institute (NHLBI) (3) · Can Tho Stroke International Services Hospital (3) · Peking Union Medical College Hospital (3) · Acotec Scientific Co., Ltd (2) · Beijing Tiantan Hospital (2) · Second Affiliated Hospital, School of Medicine, Zhejiang University (2)

What is being tested here

Drugs under test in Intracranial Arteriosclerosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Recaticimab303
Rivaroxaban233
Evolocumab203
Aspirin112
Alirocumab112
Tocilizumab111
Butylphthalide101
Colchicine101
Probucol101
PCSK9 Inhibitor101

Drug classes tested here PCSK9 inhibitors 3 open

Coming up

7phase 3 studies under way
18studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 28 Intracranial Arteriosclerosis studies recruiting now, 11 (39%) set no upper age limit and 1 (4%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (7%) take healthy volunteers.

Recruiting studies that take each age, of 28
AgeWomenMen
100 (0%)0 (0%)
1820 (71%)20 (71%)
3024 (86%)24 (86%)
4027 (96%)27 (96%)
5028 (100%)28 (100%)
6528 (100%)28 (100%)
7528 (100%)28 (100%)
8517 (61%)17 (61%)

Across all 102 studies, recruiting or not: 13% stop at 75 or younger and 3% at 65; 4% take children; 0% are for women only and 1% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 102. Browse all 102 → or search them.